Molecular biology and cytogenetics of soft tissue sarcomas: Relevance for targeted therapies
- 1 January 2004
- book chapter
- review article
- Published by Springer Science and Business Media LLC
- Vol. 120, 99-116
- https://doi.org/10.1007/1-4020-7856-0_6
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Response of extraabdominal desmoid tumors to therapy with imatinib mesylateCancer, 2002
- Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal TumorsNew England Journal of Medicine, 2002
- Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor)Oncogene, 1999
- Loss ofNF1 allele in schwann cells but not in fibroblasts derived from an NF1-associated neurofibromaGenes, Chromosomes and Cancer, 1999
- Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal TumorsScience, 1998
- The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumourNature Genetics, 1997
- A recurring translocation, t(11;22)(p13;q11.2), characterizes intra-abdominal desmoplastic small round-cell tumorsCancer Genetics and Cytogenetics, 1993
- Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesisNature Genetics, 1993
- Cytogenetic findings in liposarcoma correlate with histopathologic subtypesCancer, 1992
- Recurrent breakpoints at 9q31 and 22q12.2 in extraskeletal myxoid chondrosarcomaCancer Genetics and Cytogenetics, 1988